Ali Mostashari

Member Since 2020

Ali Mostashari

Chief Executive Officer

LifeNome

New York City Area

Ali Mostashari, Ph.D. is a co-founder of LifeNome (https://www.lifenome.com), a Precision Health AI company headquartered in New York City. LifeNome leverages biological, physiological, and behavioral data to provide science-based precision needs and risk assessments and targeted health and wellness interventions in the health and wellness sector. Concurrently he serves as a Member of the Global Futures Council of the World Economic Forum. Prior to LifeNome, Ali was an Associate Professor and Program Director at the School of Systems and Enterprises at Stevens Institute of Technology, where he directed the institute's Smart Cities initiative and systems thinking research. From 2004-2008 he served as a LEAD Program Manager and Strategic Resource Manager respectively at the United Nations Development Programme (UNDP) in New York City overseeing a development portfolio of over $1.2 billion.


SKILLS

  • Artificial Intelligence
  • Genomics
  • Precision Health

RECENT CONTENT

June 17th, 2021

13 Significant Business Challenges Teaching Leaders Valuable Lessons

Business challenges can be difficult to face, but they can also provide an incredible learning experience for company leaders.

May 21st, 2021

14 Important Keys to Creating Natural Business Relationships

Whether it's an employee, a partner or a potential client, business success depends on nurturing genuine, organic relationships.

April 13th, 2021

How Food Companies and Health Companies Can Collaborate for a Better Future

March 15th, 2021

13 Ways to Maintain Brand Relevance Amidst Changing Industry Trends

Your industry is constantly changing. Learn how to change your brand along with it.


COMPANY INFO

LifeNome

LifeNome is a Precision Health AI company headquartered in New York City. LifeNome leverages biological, physiological, and behavioral data to hyper-personalize needs and interventions for health, nutrition, and personal care/beauty. LifeNome's patented Genomics AI engine is considered one of the world's most advanced polygenic assessment engines, and is validated over a dataset of more than 530,000 patient genotype-phenotype profiles. The three co-founders of the company are each in the top 20 cited scholars in their respective fields of computational genomics, complexity science, and semantic networks. More than half the team has Ph.Ds. Awards and Recognitions: - World Economic Forum Global Innovator (2020) - Global winner Zurich World Innovation Championship (2019) - Top 10 AI Companies in Health (Analytics Insight, 2019) - Finalist in NVIDIA Inception Accelerator (2018) - Johnson and Johnson Quickfire (2018) - COTY Incubator Awards (2018) - Ranked Top Health DNA Company (DNA Testing Choice, 2017) - Top 10 AI Companies in Health (Disruptor Daily 2017) - Top 3 AI Companies (out of 135) (Bosch Venture Forum, 2017) - Top 10 Genomics Solutions Providers (PharmaTech 2017) - Key player in Genomics 2.0 (UBS, 2016)


AREA OF FOCUS

  • Precision Health
  • Artificial Intelligence
  • Genomics

INDUSTRY

Health